Mounjaro's sales dip: How cheap generics are redrawing India's GLP-1 market The arrival of cheaper semaglutide alternatives signals that the Indian obesity drug market has moved from a launch-led boom into something more structurally competitive Eli Lilly's Mounjaro posted its first monthly sales drop in India in Marcha Rs 20-crore decline, from roughly Rs 135 crore in February to Rs 114 crorejust days after a clutch of Indian generics entered the country's booming GLP-1 market
Many commenters indicated that hospitals would need additional time to review new guidance, develop plans for updating the files, coordinate with vendors, encode the data, validate for accuracy, and refresh and post the files
Iacono F, Prezioso D, Ruffo A et al: Tunical plication in the management of penile curvature due La Peyronie's disease
Though melanotan II has a myriad of side effects, a similar peptide called melanotan I can be safely inserted by dermatologists under the skin to treat people with intense sun sensitivity, according to Rogers
Let us assist you
To confirm GF status, microbiological assays were performed on a monthly basis by culturing feces, bedding, and drinking water in thioglycollate medium (DIFCO, Camarillo, CA)